Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026
Apr 14, 2026, 12:08

Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026

Enrico Ferro, Electrophysiology Fellow at Beth Israel Lahey Health, Clinical Investigator at Richard A. and Susan F. Smith Center for Outcomes Research, shared on LinkedIn:

”It was great to present our latest study at EHRA 2026 in Paris for the Young Investigator Award.

We ran one of the largest comparative safety analyses of PFA vs radiofrequency ablation for AF, performed at Beth Israel Deaconess Medical Center (large volume, tertiary care center, >1,500 PVI per year).

Main study findings:

  • Large study cohort of ~4,000 patients (2,000 PFA vs 2,000 RF);
  • 2 strokes (0.1%) in the RF arm (2022-2024);
  • 10 strokes (0.5%) in the PF arm (2024-2026);
  • Strokes were not clustered at the time of PF adoption. They were evenly distributed throughout the study period;
  • There was no correlation between strokes and physician experience or procedural volume – there was no learning curve effect;
  • We report stroke rates with other commercial PFA platforms beyond Farapulse, with a sizable amount of Sphere 9 cases (~500 pts);
  • These data show a uniform stroke rate across PFA platforms (~0.4%) and preliminarily suggest a possible PFA class effect.
  • Of note, posterior wall isolation was performed in 60% of PF cases, vs only 30% of RF cases. As expected, there is more extensive ablation with PFA, and we need to accrue more stroke events to power a mediator model and understand if more extensive ablation may explain the higher stroke rate.

In summary, our study found that the modern ‘PFA strategy’ seems associated with a significantly higher stroke risk, compared to the ‘RF strategy’.

As we accrue events and increase power, we will re-run the model to understand which specific element(s) of the PFA strategy may explain the high observed stroke rate.

Stay tuned!”

Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026

Stay updated with Hemostasis Today.